| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | ESI 09 |
|---|
| Description | EPAC inhibitor. Inhibits EPAC-mediated insulin releases from pancreatic β cells. Selective for EPAC over PKA. Decreases migration and invasion of AsPc-1 and PANC-1 pancreatic cancer cells in vitro. Purity 98%. MW (observed): 330.77 |
|---|
| Size | 10 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | α-[(2-(3-Chlorophenyl)hydrazinylidene]-5-(1,1-dimethylethyl)-β-oxo-3-isoxazolepropanenitrile |
|---|
| Gene, Accession, CAS # | CAS: 263707-16-0 |
|---|
| Catalog # | 4773/10 |
|---|
| Price | |
|---|
| Order / More Info | ESI 09 from TOCRIS BIOSCIENCE
|
|---|
| Product Specific References | PubMed: 26649942, 30397349 |
|---|
| 產(chǎn)品資料 |
|
|